Titlebook: Renal Cancer; Current Status and I Christopher Anderson,Mehran Afshar Book 2022 Springer Nature Switzerland AG 2022 Endoscopic Surgery.Cogn

只看該作者 · 發(fā)表于 2025-4-1 02:54:16

Pathological Classification and Biomarkers,tline the key features of the different sub-types of RCC, including those associated with hereditary syndromes. We describe the characteristics of 2 ‘emerging’ entities that may be formally recognised in the future and briefly discuss the role of novel biomarkers in RCC.

只看該作者 · 發(fā)表于 2025-4-1 06:23:32

只看該作者 · 發(fā)表于 2025-4-1 13:24:19

只看該作者 · 發(fā)表于 2025-4-1 17:58:53

reatment, psychology, and future innovations...?The book provides a valuable resource for the full spectrum of clinicians involved in the multidisciplinary management of Renal Cancer..978-3-030-84758-6978-3-030-84756-2

只看該作者 · 發(fā)表于 2025-4-1 20:06:04

		自動(dòng)登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點(diǎn)評(píng)	投稿經(jīng)驗(yàn)總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-20 21:52
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved